eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Middle Ear & Mastoid
Middle Ear, Chronic Suppurative Otitis, Medical Treatment
Updated: Jul 7, 2009
Introduction
Background
Chronic suppurative otitis media (CSOM) is a disease well known to otolaryngologists. This disease differs from chronic serous otitis media. Chronic serous otitis media may be defined as a middle ear effusion, without perforation, which is reported to persist more than 1-3 months, depending on the author. CSOM is a perforated tympanic membrane with persistent drainage from the middle ear. The chronically draining ear can be difficult to treat for a variety of reasons. This article presents the pathophysiology of the disease, treatment alternatives, and complications.1
The ancient Egyptians recognized CSOM as a disease of the ear and treated it with fluids of duck grease, borax, and cow milk. Traditional healers in India recommended both medicinal and behavioral treatments. They advised drinking butter, maintaining silence, and avoiding fatigue to cure CSOM. Hippocrates understood the recurrent nature of CSOM and placed patients on different medical and behavioral therapies, depending on the time course of their suppuration. Initially, he prescribed hot water, human milk, and sweet wine, along with avoiding the sun, strong wind, and smoky rooms. For recurrent cases, he added a topical powder consisting of lead oxide and lead carbonate.
CSOM is defined as chronic otorrhea (ie, >6-12 wk) through a perforated tympanic membrane (TM).2,3 Chronic suppuration can occur with or without cholesteatoma, and the clinical history of both conditions can be very similar. The treatment plan for cholesteatoma always includes tympanomastoid surgery with medical treatment as an adjunct. Cholesteatoma and its management are not considered in this article.
Pathophysiology
CSOM is initiated by an episode of acute infection. The pathophysiology of CSOM begins with irritation and subsequent inflammation of the middle ear mucosa. The inflammatory response creates mucosal edema. Ongoing inflammation eventually leads to mucosal ulceration and consequent breakdown of the epithelial lining. The host's attempt at resolving the infection or inflammatory insult manifests as granulation tissue, which can develop into polyps within the middle ear space. The cycle of inflammation, ulceration, infection, and granulation tissue formation may continue, destroying surrounding bony margins and ultimately leading to the various complications of CSOM.
Pseudomonas aeruginosa, Staphylococcus aureus, Proteus species, Klebsiella pneumoniae, and diphtheroids are the most common bacteria cultured from chronically draining ears. Anaerobes and fungi may grow concurrently with the aerobes in a symbiotic relationship. The clinical significance of this relationship, although unproven, is theorized to be an increased virulence of the infection. Understanding the microbiology of this disease enables the clinician to create a treatment plan with the greatest efficacy and least morbidity.
Microbiology
P aeruginosa is the most commonly recovered organism from the chronically draining ear. Various researchers over the past few decades have recovered pseudomonads from 48-98% of patients with CSOM.
P aeruginosa uses pili to attach to necrotic or diseased epithelium of the middle ear. Once attached, the organism produces proteases, lipopolysaccharide, and other enzymes to prevent normal immunologic defense mechanisms from fighting the infection. The ensuing damage from bacterial and inflammatory enzymes creates further damage, necrosis, and, eventually, bony erosion leading to some of the complications of CSOM. Fortunately, in the immunocompetent individual, the infection rarely causes serious complications or disseminated disease. Pseudomonal infections commonly resist macrolides, extended-spectrum penicillins, and first- and second-generation cephalosporins. This can complicate treatment plans, especially in children.
S aureus is the second most common organism isolated from chronically diseased middle ears. Reported data estimate infection rates from 15-30% of culture positive draining ears. The remainder of infections is caused by a large variety of gram-negative organisms. Klebsiella (10-21%) and Proteus (10-15%) species are slightly more common than other gram-negative organisms.
Five to 10% of infections are polymicrobial in etiology, often demonstrating a combination of gram-negative organisms and S aureus. The anaerobes (Bacteroides, Peptostreptococcus, Peptococcus) and fungi (Aspergillus, Candida) complete the spectrum of colonizing organisms in this disease. The anaerobes make up 20-50% of the isolates in CSOM and tend to be associated with cholesteatoma. Fungi have been reported in up to 25% of cases, but their pathogenic contribution to this disease is unclear.
Frequency
United States
The larger the TM perforation, the more likely the patient is to develop CSOM. The risk of developing otorrhea (but not necessarily CSOM) through a ventilation tube is reportedly 21-50%. Annually, more than a million tubes are placed to treat recurrent otitis media and otitis media with effusion. Studies report that 1-3% of patients with ventilation tubes develop CSOM.
Some studies estimate the yearly incidence of CSOM to be 39 cases per 100,000 persons in children and adolescents aged 15 years and younger.
International
In Britain, 0.9% of children and 0.5% of adults have CSOM. In Israel, only 0.039% of children are affected.
Mortality/Morbidity
Much of the morbidity of CSOM comes from the associated conductive hearing loss and the social stigma of an often fetid fluid draining from the affected ear. The mortality of CSOM arises from associated intracranial complications. CSOM itself is not a fatal disease. Although some studies report sensorineural hearing loss as a morbid complication of CSOM, other evidence conflicts with this claim.
Race
Certain population subsets are at increased risk for developing CSOM. The American Indian and Eskimo demonstrate an increased risk of infection. Eight percent of American Indians and up to 12% of Eskimos are affected by CSOM. The anatomy and function of the eustachian tube play a significant role in this increased risk. The eustachian tube is wider and more open in these populations than in others, thus placing them at increased risk for nasal reflux of bacteria common to AOM and recurrent AOM and leading to more frequent development of CSOM. Other populations at increased risk include children from Guam, Hong Kong, South Africa, and the Solomon Islands.
Sex
Prevalence of CSOM appears to be distributed equally between males and females.
Age
Exact prevalence in different age groups is unknown, though some studies estimate the yearly incidence of CSOM to be 39 cases per 100,000 individuals in children and adolescents aged 15 years and younger.4
Clinical
History
Patients with CSOM present with a draining ear of some duration and a premorbid history of recurrent AOM, traumatic perforation, or placement of ventilation tubes. Typically, they deny pain or discomfort.
- A common presenting symptom is hearing loss in the affected ear.
- Reports of fever, vertigo, and pain should raise concern about intratemporal or intracranial complications.
- A history of persistent CSOM after appropriate medical treatment should alert the physician to consider cholesteatoma.
Physical
- The external auditory canal may or may not be edematous and is typically not tender.
- The discharge varies from fetid, purulent, and cheeselike to clear and serous.
- Granulation tissue is often seen in the medial canal or middle ear space.
- The middle ear mucosa visualized through the perforation may be edematous or even polypoid, pale, or erythematous.
Causes
The diagnosis of CSOM requires a perforated TM. These perforations may arise traumatically, iatrogenically with tube placement, or after an episode of AOM, which decompresses through a tympanic perforation.1
The mechanism of infection of the middle ear cleft is postulated to be translocation of bacteria from the external auditory canal through a perforation into the middle ear. Some authors suggest that the pathogenic organisms may enter through reflux of the eustachian tube. The data supporting this theory are inconclusive. Most of the pathogenic bacteria are those common to the external auditory canal.
The risk of developing otorrhea (but not necessarily CSOM) through a ventilation tube is reportedly 21-50%. Annually, more than a million tubes are placed in the United States for recurrent otitis media and otitis media with effusion. Studies have reported that 1-3% of patients with ventilation tubes develop this disease.
The risk of developing CSOM increases with the following circumstances4 :
- A history of multiple episodes of AOM
- Living in crowded conditions
- Daycare facility attendance
- Being a member of a large family
Studies trying to correlate the frequency of the disease with parental education, passive smoke, breastfeeding, socioeconomic status, and the annual number of upper respiratory tract infections are inconclusive.
Patients with craniofacial anomalies are special populations at risk for CSOM. Cleft palate, Down syndrome, cri du chat syndrome, choanal atresia, cleft lip, and microcephaly are other diagnoses that increase the risk of CSOM, presumably from altered eustachian tube anatomy and function.
More on Middle Ear, Chronic Suppurative Otitis, Medical Treatment |
Overview: Middle Ear, Chronic Suppurative Otitis, Medical Treatment |
| Differential Diagnoses & Workup: Middle Ear, Chronic Suppurative Otitis, Medical Treatment |
| Treatment & Medication: Middle Ear, Chronic Suppurative Otitis, Medical Treatment |
| Follow-up: Middle Ear, Chronic Suppurative Otitis, Medical Treatment |
| Multimedia: Middle Ear, Chronic Suppurative Otitis, Medical Treatment |
| References |
| Further Reading |
| Next Page » |
References
Vikram BK, Khaja N, Udayashankar SG, Venkatesha BK, Manjunath D. Clinico-epidemiological study of complicated and uncomplicated chronic suppurative otitis media. J Laryngol Otol. May 2008;122(5):442-6. [Medline].
Matsuda Y, Kurita T, Ueda Y, Ito S, Nakashima T. Effect of tympanic membrane perforation on middle-ear sound transmission. J Laryngol Otol. May 2009;123 Suppl 31:81-9. [Medline].
Wright D, Safranek S. Treatment of otitis media with perforated tympanic membrane. Am Fam Physician. Apr 15 2009;79(8):650, 654. [Medline].
van der Veen EL, Schilder AG, van Heerbeek N, Verhoeff M, Zielhuis GA, Rovers MM. Predictors of chronic suppurative otitis media in children. Arch Otolaryngol Head Neck Surg. Oct 2006;132(10):1115-8. [Medline].
Smith JA, Danner CJ. Complications of chronic otitis media and cholesteatoma. Otolaryngol Clin North Am. Dec 2006;39(6):1237-55. [Medline].
Agro AS, Garner ET, Wright JW 3rd. Clinical trial of ototopical ofloxacin for treatment of chronic suppurative otitis media. Clin Ther. Jul-Aug 1998;20(4):744-59. [Medline].
Bance M, Rutka JA. Topical treatment for otorrhea: issues and controversies. J Otolaryngol. Aug 2005;34 Suppl 2:S52-5. [Medline].
Brown OE, Meyerhoff WL. Complications and Sequelae of Chronic Suppurative Otitis Media. Ann Otol Rhinol Laryngol. 1988;97(suppl 131):38-40.
Consensus Panel, Hannley MT, Dennenny III JC. Use of Ototopical Antibiotics in Treating 3 Common Ear Diseases. Otol Head Neck Surg. 2000;934-40.
Dohar JE. Old and New Ototopical Agents for the Acute and Chronic Draining Ear. Seminars in Otitis Media Management. 1998;1:1-14.
Dohar JE, Alper CM, Rose EA. Treatment of chronic suppurative otitis media with topical ciprofloxacin. Ann Otol Rhinol Laryngol. Oct 1998;107(10 Pt 1):865-71. [Medline].
Dohar JE, Kenna MA, Wadowsky RM. Therapeutic implications in the treatment of aural Pseudomonas infections based on in vitro susceptibility patterns. Arch Otolaryngol Head Neck Surg. Sep 1995;121(9):1022-5. [Medline].
Esposito S, D'Errico G, Montanaro C. Topical and oral treatment of chronic otitis media with ciprofloxacin. A preliminary study. Arch Otolaryngol Head Neck Surg. May 1990;116(5):557-9. [Medline].
Esposito S, Noviello S, D'Errico G, Montanaro C. Topical ciprofloxacin vs intramuscular gentamicin for chronic otitis media. Arch Otolaryngol Head Neck Surg. Aug 1992;118(8):842-4. [Medline].
Force RW, Hart MC, Plummer SA. Topical ciprofloxacin for otorrhea after tympanostomy tube placement. Arch Otolaryngol Head Neck Surg. Aug 1995;121(8):880-4. [Medline].
Gehanno P. Multicenter study of the efficacy and safety of oral ciprofloxacin in the treatment of chronic suppurative otitis media in adults. The French Study Group. Otolaryngol Head Neck Surg. Jul 1997;117(1):83-90. [Medline].
Hampel B, Hullmann R, Schmidt H. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use--safety report. Pediatr Infect Dis J. Jan 1997;16(1):127-9; discussion 160-2. [Medline].
Hannley MT, Denneny JC 3rd, Holzer SS. Use of ototopical antibiotics in treating 3 common ear diseases. Otolaryngol Head Neck Surg. Jun 2000;122(6):934-40. [Medline].
Ibekwe AO, al Shareef Z, Benayam A. Anaerobes and fungi in chronic suppurative otitis media. Ann Otol Rhinol Laryngol. Aug 1997;106(8):649-52. [Medline].
Indudharan R, Haq JA, Aiyar S. Antibiotics in chronic suppurative otitis media: a bacteriologic study. Ann Otol Rhinol Laryngol. May 1999;108(5):440-5. [Medline].
Kaplan DM, Fliss DM, Kraus M. Audiometric findings in children with chronic suppurative otitis media without cholesteatoma. Int J Pediatr Otorhinolaryngol. Apr 1996;35(2):89-96. [Medline].
Kenna MA. Etiology and Pathogenesis of Chronic Suppurative Otitis Media. Ann Otol Rhinol Laryngol. 1988;97(Suppl 131):16-17.
Kenna MA. Microbiology of Chronic Suppurative Otitis Media. Ann Otol Rhinol Laryngol. 1988;97(suppl 131):9-10.
Kenna MA. Treatment of Chronic Suppurative Otitis Media. Otolaryngol Clinics North Am. 1994;27:457-71.
Kenna MA, Bluestone CD, Reilly JS. Medical management of chronic suppurative otitis media without cholesteatoma in children. Laryngoscope. Feb 1986;96(2):146-51. [Medline].
Kiris M, Berktas M, Egeli E. The efficacy of topical ciprofloxacin in the treatment of chronic suppurative otitis media. Ear Nose Throat J. Nov 1998;77(11):904-5, 909. [Medline].
[Best Evidence] Macfadyen CA, Acuin JM, Gamble C. Topical antibiotics without steroids for chronically discharging ears with underlying eardrum perforations. Cochrane Database Syst Rev. 2005;CD004618. [Medline].
Meyerhoff WL. Pathology of Chronic Suppurative Otitis Media. Ann Otol Rhinol Laryngol. 1988;97(suppl 131):21-24.
Meyerhoff WL, Kim CS, Paparella MM. Pathology of chronic otitis media. Ann Otol Rhinol Laryngol. Nov-Dec 1978;87(6 Pt 1):749-60. [Medline].
Noordzij JP, Dodson EE, Ruth RA. Chronic otitis media and sensorineural hearing loss: is there a clinically significant relation?. Am J Otol. Jul 1995;16(4):420-3. [Medline].
Roland PS, Dohar JE, Lanier BJ, et al. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of granulation tissue in children with acute otitis media with otorrhea through tympanostomy tubes. Otolaryngol Head Neck Surg. Jun 2004;130(6):736-41. [Medline].
Roland PS, Parry DA, Stroman DW. Microbiology of acute otitis media with tympanostomy tubes. Otolaryngol Head Neck Surg. Oct 2005;133(4):585-95. [Medline].
Sade J, Berco E. Bone destruction in chronic otitis media. A histopathological study. J Laryngol Otol. May 1974;88(5):413-22. [Medline].
Seven H, Coskun BU, Calis AB, et al. Intracranial abscesses associated with chronic suppurative otitis media. Eur Arch Otorhinolaryngol. Oct 2005;262(10):847-51. [Medline].
Smith AW, Hatcher J, Mackenzie IJ. Randomised controlled trial of treatment of chronic suppurative otitis media in Kenyan schoolchildren. Lancet. Oct 26 1996;348(9035):1128-33. [Medline].
Thomsen J, Jorgensen MB, Bretlau P. Bone resorption in chronic otitis media. A histological and ultrastructural study. I. Ossicular necrosis. J Laryngol Otol. Oct 1974;88(10):975-81. [Medline].
Wang PC, Nadol JB Jr, Merchant S. Validation of outcomes survey for adults with chronic suppurative otitis media. Ann Otol Rhinol Laryngol. Mar 2000;109(3):249-54. [Medline].
Wintermeyer SM, Hart MC, Mahata MC. Efficacy of Ototopical Ciprofloxacin ini Pediatric Patients With Otorrhea. Otolaryngol Head Neck Surg. 1997;116:450-53.
Wintermeyer SM, Nahata MC. Chronic suppurative otitis media. Ann Pharmacother. Sep 1994;28(9):1089-99. [Medline].
Wright CG, Meyerhoff WL. Ototopical Agents: Efficacy or Toxicity in Humans. Ann Otol Rhinol Laryngol. 1988;97(suppl 131):30-32.
Further Reading
Clinical guidelines
Evidence based clinical practice guideline for medical management of acute otitis media in children 2 months to 13 years of age.
Cincinnati Children's Hospital Medical Center - Hospital/Medical Center. 1999 (revised 2004 Oct 29; reviewed 2006 Aug). 16 pages. NGC:003958
Otitis media.
University of Michigan Health System - Academic Institution. 1997 Nov (revised 2007 Jul). 12 pages. NGC:006032
Adapting your practice: treatment and recommendations for homeless children with otitis media.
Health Care for the Homeless (HCH) Clinician's Network - Medical Specialty Society
National Health Care for the Homeless Council, Inc. - Private Nonprofit Organization. 2003 (revised 2008). 29 pages. NGC:006943
Clinical trials
Magnetic Resonance (MR) Imaging in the Post Operative Follow-up of Cholesteatoma in Children
Study of Different Kinds of Ear Tubes
Related eMedicine topics
Otitis Media
Middle Ear, Acute Otitis Media, Surgical Treatment
Middle Ear, Otitis Media With Effusion
Middle Ear, Chronic Suppurative Otitis, Surgical Treatment
Middle Ear, Acute Otitis Media, Medical Treatment
Keywords
chronic otitis media, chronic perforated tympanic membrane, perforated tympanic membrane, chronically draining ear, chronic suppurative otitis media, CSOM, ear infection, chronic otorrhea, cholesteatoma, acute otitis media, AOM, middle ear drainage


Overview: Middle Ear, Chronic Suppurative Otitis, Medical Treatment